HEARTEN is a project funded by the European Union, with twelve partners from six European countries; three Universities, two research centers, five SMEs, one industry partner and one Healthcare authority partner. HEARTEN consortium join forces to engage all actors related to the management of patients suffering from Heart Failure (HF), towards developing a multi-stakeholder patient centered mHealth ecosystem.
The three-year project targets HF, a disease experienced globally by 26 million people with an annual cost to insurers estimated to be approximately 6.000€ per person. The recognition of non-adherent HF patients is important since, even if these patients are fortunate to have at their disposal a plethora of guidelines and health-based knowledge, the integration of this knowledge in their life becomes difficult. Developing and delivering an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior change regarding their adherence and compliance is an significant challenge.
Heart Failure is a chronic disease which occurs when the heart is unable to pump sufficiently to maintain the blood flow to meet the needs of the body. Among the causes of Heart Failure are coronary artery disease, myocardial infarction, high blood pressure, cardiomyopathy, etc. Today, in developed countries, 2% of the adult population suffers from Heart Failure and this percentage reaches 6-8% for those being over 65.
An innovative mobile platform will allow patients suffering from Heart Failure to be managed and linked with Healthcare professionals, caregivers, their families, physical activity experts, nutritionists, just using their smartphones. The mobile platform will be developed in the framework of the HEARTEN project, which will receive approximately 4.5 million euros in funding from the European Commission, and which started in January 2015.
A breath sensor will be integrated into the smartphone and a saliva sensor will be integrated into the patient’s cup; these are the key elements of HEARTEN of monitoring the changes in the patient’s health status. In addition, sensors will monitor the activity of the heart, the blood pressure and the physical activity of the patient. With the support of an intelligent processing module and data collection and analysis, it will be possible to provide the HF patient with the appropriate therapeutic changes and suggestions to improve adherence and intervene before frailty incidences occur.